• 1
    Working Party of the Standing Medical Advisory Committee on Sickle Cell, Thalassaernia and other Haemoglobinopathies, Report, London : HMSO, 1993.
  • 2
    Bassett P, Beuzard Y, Garel MC, Rosa J. Isoelectric focusing in human haemoglobins: its application to screening, to characterization of 70 variants and to study of modified fractions of normal haemoglobins. Blood 1978; 51: 971982.
  • 3
    Johnson CS, Moyes D, Schroeder WA, Shelton JR, Beutler E. Hemoglobin Pasadena alpha 2 beta (E 19) leads to Arg. Identification by high performance liquid chromatography of a new unstable variant with increased oxygen affinity. Biochimica et Biophysica Acta 1980; 623: 360367.
  • 4
    Thalassaemia Working Party of the BCSH General Haematology Task Force, Guidelines for investigation of the α and β thalassaemia traits. J Clin Pathol 1994; 47: 4, 289295.
  • 5
    Huntsman RG, Barclay GPT, Canning DM, Yawson GI. A rapid whole blood solubility test to differentiate the sickle cell trait from sickle cell anaemia. J Clin Pathol 1970; 23: 781783.
  • 6
    Brozovic M, Henthorn J. Investigation of abnormal haemoglobins and thalassaemia. In: DacieJV, LewisSM, editors. Practical Haematology, 8th edition. London : Churchill Livingstone, 1995.
  • 7
    Modell B, Anionwu EN. Guidelines for screening for haemoglobin disorders: services specifications for low and high prevalence DHAs. In: Ethnicity and Health: Reviews of Literature and Guidance for Purchasers in the Areas of Cardiovascular Disease, Mental Health and Haemoglobinopathies. York : University of York, NHS Centre for Reviews and Dissemination CRD Report 5, Part 4 127224, 1996.
  • 8
    Platt OS, Brambilla DJ, Rosse WF et al. Mortality in sickle cell disease—life expectancy and risk factors for early death. N Eng J Med 1994; 330: 16391643.
  • 9
    Hickman M, Model B, Greengross Pet et al. Mapping the prevalence of sickle cell and β Thalassaemia in England: estimating and validating ethnic-specific rates. Br J Haematol 1999; 104: 860867.
  • 10
    Greengross P, Hickman M, Gill M, Dugan B, Davies SC. Outcomes of universal antenatal screening for haemoglobinopathies. J Med Screen 1998; 6: 310.